{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T06:57:44Z","timestamp":1780988264107,"version":"3.54.1"},"reference-count":21,"publisher":"Wiley","issue":"7","license":[{"start":{"date-parts":[[2019,12,13]],"date-time":"2019-12-13T00:00:00Z","timestamp":1576195200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"},{"start":{"date-parts":[[2019,12,13]],"date-time":"2019-12-13T00:00:00Z","timestamp":1576195200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Addiction"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1111\/add.14823","type":"journal-article","created":{"date-parts":[[2019,9,14]],"date-time":"2019-09-14T20:53:46Z","timestamp":1568494426000},"page":"1203-1205","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Extra\u2010medical use of antipsychotics: what can be learnt from experiences with other prescription medicines?"],"prefix":"10.1111","volume":"115","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0452-8470","authenticated-orcid":false,"given":"Natasa","family":"Gisev","sequence":"first","affiliation":[{"name":"National Drug and Alcohol Research Centre UNSW, Sydney  Sydney Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3065-7495","authenticated-orcid":false,"given":"Jonathan","family":"Brett","sequence":"additional","affiliation":[{"name":"Clinical Therapeutics and Alcohol and Drug Services St Vincent's Hospital  Sydney Australia"},{"name":"Centre for Big Data Research in Health UNSW Sydney  Sydney Australia"},{"name":"School of Medicine (Psychology) University of Tasmania  Hobart Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5705-2026","authenticated-orcid":false,"given":"Amy","family":"Peacock","sequence":"additional","affiliation":[{"name":"National Drug and Alcohol Research Centre UNSW, Sydney  Sydney Australia"},{"name":"School of Medicine (Psychology) University of Tasmania  Hobart Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2019,12,13]]},"reference":[{"key":"e_1_2_3_2_1","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.12927"},{"key":"e_1_2_3_3_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrendo.2011.156"},{"key":"e_1_2_3_4_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.2009.01425.x"},{"key":"e_1_2_3_5_1","doi-asserted-by":"publisher","DOI":"10.2165\/11632030-000000000-00000"},{"key":"e_1_2_3_6_1","first-page":"13","article-title":"Comparison of quetiapine abuse and misuse reports to the FDA adverse event reporting system with other second\u2010generation antipsychotics","author":"Evoy K. E.","year":"2019","journal-title":"Subst Abuse"},{"key":"e_1_2_3_7_1","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0000000000000814"},{"key":"e_1_2_3_8_1","first-page":"39","article-title":"Emergency department visits involving misuse and abuse of the antipsychotic quetiapine: results from the drug abuse warning network (DAWN)","volume":"9","author":"Mattson M. E.","year":"2015","journal-title":"Subst Abuse"},{"key":"e_1_2_3_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2018.03.002"},{"key":"e_1_2_3_10_1","article-title":"Prevalence and associations of quetiapine fumarate misuse among an Australian national city sample of people who regularly inject drugs","volume":"109","author":"Reddel S.","year":"2013","journal-title":"Addiction"},{"key":"e_1_2_3_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2014.07.006"},{"key":"e_1_2_3_12_1","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0b013e3182670648"},{"key":"e_1_2_3_13_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMp1011512"},{"key":"e_1_2_3_14_1","doi-asserted-by":"publisher","DOI":"10.1002\/pds.4408"},{"key":"e_1_2_3_15_1","doi-asserted-by":"publisher","DOI":"10.7326\/M17-3074"},{"key":"e_1_2_3_16_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMp1806486"},{"key":"e_1_2_3_17_1","doi-asserted-by":"crossref","unstructured":"AlpertA. PowellD. PaculaR. L.Supply\u2010side drug policy in the presence of substitutes: evidence from the introduction of abuse\u2010deterrent opioids. NBER Working Paper 23031.Cambridge MA:National Bureau of Economic Research;2017.","DOI":"10.3386\/w23031"},{"key":"e_1_2_3_18_1","first-page":"e52","article-title":"Formulary restrictions on atypical antipsychotics: impact on costs for patients with schizophrenia and bipolar disorder in Medicaid","volume":"20","author":"Seabury S. A.","year":"2014","journal-title":"Am J Manag Care"},{"key":"e_1_2_3_19_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2018.6007"},{"key":"e_1_2_3_20_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1526-4637.2005.05031.x"},{"key":"e_1_2_3_21_1","volume-title":"Assessment of abuse potential drugs: guidance for industry","author":"Center for Drug Evaluation and Research","year":"2017"},{"key":"e_1_2_3_22_1","doi-asserted-by":"publisher","DOI":"10.1111\/add.14556"}],"container-title":["Addiction"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/add.14823","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/add.14823","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/add.14823","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T05:58:27Z","timestamp":1780984707000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/add.14823"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,13]]},"references-count":21,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["10.1111\/add.14823"],"URL":"https:\/\/doi.org\/10.1111\/add.14823","archive":["Portico"],"relation":{},"ISSN":["0965-2140","1360-0443"],"issn-type":[{"value":"0965-2140","type":"print"},{"value":"1360-0443","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12,13]]},"assertion":[{"value":"2019-04-30","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-09-02","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-12-13","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}